# Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)

> **NCT01787578** · PHASE1 · WITHDRAWN · sponsor: **Thomas S. Scanlan**

## Conditions studied

- X-Linked Adrenoleukodystrophy
- Adrenomyeloneuropathy

## Interventions

- **DRUG:** Sobetirome

## Key facts

- **NCT ID:** NCT01787578
- **Lead sponsor:** Thomas S. Scanlan
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2013-04
- **Primary completion:** 2013-09
- **Final completion:** 2014-02
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** revisions to original study protocol underway
- **Last updated:** 2014-02-14


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01787578

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01787578, "Safety and Pharmacodynamic Study of Sobetirome in X-Linked Adrenoleukodystrophy (X-ALD)". Retrieved via AI Analytics 2026-07-18 from https://api.ai-analytics.org/clinical/NCT01787578. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*